NovaBay Pharmaceuticals, Inc. (NBY)
NYSEAMERICAN: NBY · Real-Time Price · USD
1.440
-0.090 (-5.88%)
Feb 27, 2026, 4:00 PM EST - Market closed
NovaBay Pharmaceuticals Market Cap
NovaBay Pharmaceuticals has a market cap or net worth of $37.62 million as of February 27, 2026. Its market cap has increased by 1,075.61% in one year.
Market Cap
37.62M
Enterprise Value
36.28M
1-Year Change
1,075.61%
Ranking
Category
Stock Price
$1.44
Market Cap Chart
Since October 26, 2007, NovaBay Pharmaceuticals's market cap has decreased from $76.50M to $37.62M, a decrease of -50.82%. That is a compound annual growth rate of -3.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 36.30M | -94.89% |
| Dec 31, 2025 | 710.70M | 24,406.90% |
| Dec 31, 2024 | 2.90M | 123.08% |
| Dec 29, 2023 | 1.30M | -63.89% |
| Dec 30, 2022 | 3.60M | -78.70% |
| Dec 31, 2021 | 16.90M | -41.92% |
| Dec 31, 2020 | 29.10M | 62.57% |
| Dec 31, 2019 | 17.90M | 35.61% |
| Dec 31, 2018 | 13.20M | -77.70% |
| Dec 29, 2017 | 59.20M | 18.64% |
| Dec 30, 2016 | 49.90M | 612.86% |
| Dec 31, 2015 | 7.00M | -78.46% |
| Dec 31, 2014 | 32.50M | -32.85% |
| Dec 31, 2013 | 48.40M | 43.62% |
| Dec 31, 2012 | 33.70M | -11.32% |
| Dec 30, 2011 | 38.00M | -1.55% |
| Dec 31, 2010 | 38.60M | -19.42% |
| Dec 31, 2009 | 47.90M | 118.72% |
| Dec 31, 2008 | 21.90M | -72.63% |
| Dec 31, 2007 | 80.00M | 4.58% |
View and export this data all the way back to 2007.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Telomir Pharmaceuticals | 44.35M |
| Sensei Biotherapeutics | 43.32M |
| Lite Strategy | 42.91M |
| Aligos Therapeutics | 42.71M |
| Veru Inc. | 41.57M |
| CervoMed | 40.62M |
| Xilio Therapeutics | 39.93M |
| Jasper Therapeutics | 39.18M |